Find updates from the Cambridge Bio Nexus team below.
Insight articles are only accessible by members, log in or sign up today.
-
Insight: What Karyopharm’s new trial data means for cancer drug development
*** This is a sample article, the information provided is an example *** The latest trial from Karyopharm has just released its new results. The selenexor compound has shown good results in the stage 3 trials. Whilst this was an expected result to the biotech world and individually has little impact it lays the path […]